Problem statement: Answer the MCQ question.
Question: Which drug exhibits a 8.297\% human ether-à-go-go related gene (hERG) inhibition at a concentration of 1uM?
Constraint: You must select none, one or more options from a, b, or c without using any other words.
Options:
a CSCC[C@H](NC(=O)OC(C)(C)C)C(=O)N1CCC(C(=O)N[C@@H](C)C(=O)NCc2ccc(F)cc2)CC1
b O=C(Nc1nnc(Cc2ccc(Cl)cc2)s1)c1cccnc1
c Cc1ccc2c(c1)c(=O)c1c3n2CCN(CC2CO2)C3CC1
Answer: c. Cc1ccc2c(c1)c(=O)c1c3n2CCN(CC2CO2)C3CC1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_1uM#}{herg_central_at_1uM__units} {herg_central_at_1uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_1uM%}
Answer: {%multiple_choice_result}. {SMILES#}
Cc1ccc2c(c1)c(=O)c1c3n2CCN(CC2CO2)C3CC1
Cc1ccc2c(c1)c(=O)c1c3n2CCN(CC2CO2)C3CC1
5-methyl-13-(oxiran-2-ylmethyl)-1,13-diazatetracyclo[7.6.1.02,7.012,16]hexadeca-2(7),3,5,9(16)-tetraen-8-one